Is operation the best option for infertile patients with digestive endometriosis?
The benefits and risks of any chosen therapeutic strategy for infertile women with digestive endometriosis should be evaluated based on a comprehensive and personalized assessment integrating clinical history, pain symptoms, patient’s age, ovarian reserve, tubal status, and endometriosis lesions.
Key Points Lay Summary
Pain Cognition Impacts Health Related Quality of Life in Women with Endometriosis
Knowing how the pain cognition influences health-related quality of life, can help better treatment for pain symptoms.
Key Points Lay Summary
Protein-Modifying Variants in the Genome and Their Role in Endometriosis
This study seeks to identify protein-modifying variants and their roles in endometriosis by comparing a discovery group of international participants to a replication cohort.
Key Points Lay Summary
An association of negative coping strategies on the presence of chronic symptoms associated with endometriosis
Focusing on the mental health aspect of endometriosis: A focus on coping strategies
Key Points Lay Summary
Institutional Violence Typically Faced by Women with Endometriosis
A woman's journey with endometriosis is difficult; some of the adversity can be attributed to the quality of institutional care an individual receives.
Key Points Lay Summary
Swimming Against the Stream: Is Surgery Worthwhile in Women with Deep Infiltrating Endometriosis and Pregnancy Intention?
First-line conservative therapy versus first-line ART in women with Deeply Infiltrating Endometriosis: A perspective
Key Points Lay Summary
The Endometriosis Fertility index Could Help Better Predict the Chance of Conceiving After Laparoscopy
Using the EFI can ensure only women who are less likely to conceive naturally use assisted reproductive technologies
Key Points Lay Summary
A New Treatment Time-Table for Controlling Endometriosis-Associated Pelvic Pain
This study uncovers a better treatment tool for endometriosis pain management in Flexible Management of Intracyclic Bleeding regimen consisting of a flexible extended estrogen/progesterone (EP) product with ethinylestradiol 20 μg/drospirenone 3 mg.
Key Points Lay Summary